Intrinsic Value

The intrinsic value of InspireMD Inc (II2) under the Base Case is 0.392 EUR per share. Compared with the current market price of 0.484 EUR, the stock appears Overvalued by 19% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

II2 Intrinsic Value
€0.392
Overvaluation 19%
Intrinsic Value
Price €0.484
Alert me when II2 is below its intrinsic value
Today €0.314 · 35.2% below the current price

II2 is cheaper than usual. Still overvalued, but less so than on 79% of days in the past 5 years.

Alternatives to II2

Fundamental Analysis

What InspireMD Does

Health Care

InspireMD makes medical devices used in blood-vessel procedures, especially stents and embolic protection systems. Its main product family is built around a thin mesh that is designed to catch debris that can break loose during treatment and travel downstream, which helps doctors treat blocked arteries more safely. The company sells to hospitals and physicians that perform cardiovascular and neurovascular procedures.

Headquarters
United States of America US
Employees
127
IPO date
Apr 12, 2013
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
InspireMD Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

NSPR Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one II2 stock?

The intrinsic value for InspireMD Inc (II2) under the Base Case is 0.392 EUR.

Is II2 stock undervalued or overvalued?

Compared with the current market price of 0.484 EUR, the stock appears Overvalued by 19% .

Back to Top